Assignee
METABOLON INC
US·33 granted patents·19 pending applications·271 citations·filing 2003–2024
Top patents by PatentIndex Score
52 records- 0197US7550258B2Methods for drug discovery, disease treatment, and diagnosis using metabolomicsMETABOLON INC·Filed 2006·Granted Jun 23, 2009·30 cites·8 claims
- 0297US7329489B2Methods for drug discovery, disease treatment, and diagnosis using metabolomicsMETABOLON INC·Filed 2003·Granted Feb 12, 2008·86 cites·78 claims
- 0396US7553616B2Methods for drug discovery, disease treatment, and diagnosis using metabolomicsMETABOLON INC·Filed 2007·Granted Jun 30, 2009·23 cites·10 claims
- 0496US7550260B2Methods for drug discovery, disease treatment, and diagnosis using metabolomicsMETABOLON INC·Filed 2007·Granted Jun 23, 2009·27 cites·9 claims
- 0589US7561975B2System, method, and computer program product for analyzing spectrometry data to identify and quantify individual components in a sampleMETABOLON INC·Filed 2007·Granted Jul 14, 2009·20 cites·19 claims
- 0688US7947453B2Methods for drug discovery, disease treatment, and diagnosis using metabolomicsMETABOLON INC·Filed 2009·Granted May 24, 2011·6 cites·11 claims
- 0787US7910301B2Methods for drug discovery, disease treatment, and diagnosis using metabolomicsMETABOLON INC·Filed 2007·Granted Mar 22, 2011·6 cites·30 claims
- 0887US7781160B2Biomarkers related to metabolic age and methods using the sameMETABOLON INC·Filed 2007·Granted Aug 24, 2010·7 cites·8 claims
- 0987US7433787B2System, method, and computer program product using a database in a computing system to compile and compare metabolomic data obtained from a plurality of samplesMETABOLON INC·Filed 2006·Granted Oct 7, 2008·8 cites·7 claims
- 1086US9977034B2Biomarkers for fatty liver disease and methods using the sameMETABOLON INC·Filed 2015·Granted May 22, 2018·5 cites·2 claims
- 1186US7884318B2Systems, methods, and computer-readable medium for determining composition of chemical constituents in a complex mixtureMETABOLON INC·Filed 2008·Granted Feb 8, 2011·19 cites·45 claims
- 1284US11061005B2Mass spectrometry assay method for detection and quantitation of organic acid metabolitesMETABOLON INC·Filed 2018·Granted Jul 13, 2021·3 cites·18 claims
- 1384US10267777B2Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessmentMETABOLON INC·Filed 2016·Granted Apr 23, 2019·4 cites·30 claims
- 1483US10890592B2Automated sample quality assessmentMETABOLON INC·Filed 2016·Granted Jan 12, 2021·3 cites·21 claims
- 1581US11181530B2Mass spectrometry method for detection and quantitation of metabolitesMETABOLON INC·Filed 2017·Granted Nov 23, 2021·3 cites·15 claims
- 1681US9910047B2Biomarkers related to insulin resistance progression and methods using the sameMETABOLON INC·Filed 2014·Granted Mar 6, 2018·5 cites·22 claims
- 1780US7949475B2System and method for analyzing metabolomic dataMETABOLON INC·Filed 2008·Granted May 24, 2011·10 cites·28 claims
- 1874US12320798B2Diagnostic methods, therapeutic agents and uses thereofMETABOLON INC·Filed 2021·Granted Jun 3, 2025·0 cites·12 claims
- 1971US10539575B2Biomarkers related to kidney function and methods using the sameMETABOLON INC·Filed 2014·Granted Jan 21, 2020·2 cites·17 claims
- 2070US10502729B2Diagnostic methods, therapeutic agents and uses thereofMETABOLON INC·Filed 2016·Granted Dec 10, 2019·1 cites·6 claims
- 2169US7807138B2Biomarkers of metabolic responses to hepatic drugsMETABOLON INC·Filed 2007·Granted Oct 5, 2010·2 cites·6 claims
- 2268US2025120927A1Cndp2 modulators and methods for their useMETABOLON INC·Filed 2024·Application pending·0 cites
- 2367US12050228B2Automated sample quality assessmentMETABOLON INC·Filed 2020·Granted Jul 30, 2024·0 cites·14 claims
- 2467US2020110069A1Diagnostic methods, therapeutic agents and uses thereofMETABOLON INC·Filed 2019·Application pending·0 cites
- 2562US2025140351A1Method for structural elucidation of small molecule components of a complex mixture, and associated apparatus and computer program productMETABOLON INC·Filed 2022·Application pending·0 cites
- 2661US2020103417A1Biomarkers related to kidney function and methods using the sameMETABOLON INC·Filed 2019·Application pending·0 cites
- 2760US10573406B2Method, apparatus and computer program product for metabolomics analysisMETABOLON INC·Filed 2015·Granted Feb 25, 2020·1 cites·21 claims
- 2856US10175233B2Biomarkers for cardiovascular diseases and methods using the sameMETABOLON INC·Filed 2015·Granted Jan 8, 2019·0 cites·8 claims
- 2955US2018203021A1Biomarkers Related to Insulin Resistance Progression and Methods Using the SameMETABOLON INC·Filed 2018·Application pending·0 cites
- 3055US2016116461A1Biomarkers Related To Metabolic Age and Methods Using The SameMETABOLON INC·Filed 2015·Application pending·0 cites
- 3152US11680042B2Compounds, reagents, and uses thereofMETABOLON INC·Filed 2018·Granted Jun 20, 2023·0 cites·20 claims
- 3252US11181535B2Isotopically-labeled cholesteryl ester internal standard composition and kitMETABOLON INC·Filed 2016·Granted Nov 23, 2021·0 cites·4 claims
- 3352US2020025729A1Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessmentMETABOLON INC·Filed 2019·Application pending·0 cites
- 3452US2014303228A1Biomarkers for Amyotrophic Lateral Sclerosis and Methods Using the SameMETABOLON INC·Filed 2012·Application pending·0 cites
- 3551US11527306B2Streamlined method for analytical validation of biochemicals detected using an untargeted mass-spectrometry platformMETABOLON INC·Filed 2018·Granted Dec 13, 2022·0 cites·19 claims
- 3650US2010279337A1Biomarkers Related To Metabolic Age and Methods Using The SameMETABOLON INC·Filed 2010·Application pending·0 cites
- 3749US10865183B2Compounds, reagents, and uses thereofMETABOLON INC·Filed 2017·Granted Dec 15, 2020·0 cites·19 claims
- 3849US2016245814A1Biomarkers for kidney cancer and methods using the sameMETABOLON INC·Filed 2014·Application pending·0 cites
- 3947US12332225B2Method for determining small molecule components of a complex mixture, and associated apparatus and computer program productMETABOLON INC·Filed 2021·Granted Jun 17, 2025·0 cites·54 claims
- 4046US2016356798A1Biomarkers of de novo lipogenesis and methods using the sameMETABOLON INC·Filed 2014·Application pending·0 cites
- 4145US2014201249A1Method, system, and computer program product for associating visual indicia with a metabolomics analysisMETABOLON INC·Filed 2013·Application pending·0 cites
- 4244US2019120855A1Biomarkers for Fatty Liver Disease and Methods Using the SameMETABOLON INC·Filed 2018·Application pending·0 cites
- 4343US2022050090A1Mass spectrometry assay method for detection and quantitation of microbiota related metabolitesMETABOLON INC·Filed 2019·Application pending·0 cites
- 4441US11536726B2Mass spectrometry assay method for detection and quantitation of liver function metabolitesMETABOLON INC·Filed 2019·Granted Dec 27, 2022·0 cites·13 claims
- 4541US11387087B2Method for analyzing small molecule components of a complex mixture, and associated apparatus and computer program productMETABOLON INC·Filed 2020·Granted Jul 12, 2022·0 cites·58 claims
- 4637US2015065366A1Biomarkers for Bladder Cancer and Methods Using the SameMETABOLON INC·Filed 2012·Application pending·0 cites
- 4737US2022221433A1Mass spectrometry assay methods for detection of metabolitesMETABOLON INC·Filed 2020·Application pending·0 cites
- 4835US2018314790A1System, Method and Apparatus for Determining the Effect of Genetic VariantsMETABOLON INC·Filed 2015·Application pending·0 cites
- 4933US11619636B2Mass spectrometry assay method for detection and quantitation of kidney function metabolitesMETABOLON INC·Filed 2017·Granted Apr 4, 2023·0 cites·12 claims
- 5032US2017370954A1Biomarkers for Fatty Liver Disease and Methods Using the SameMETABOLON INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when METABOLON INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →